Stock KBLB KRAIG BIOCRAFT LABORATORIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Kraig Biocraft Laboratories, Inc.

Equities

KBLB

US50075W1045

Delayed OTC Markets
Other stock markets
 12:01:25 2024-04-30 pm EDT 		5-day change 1st Jan Change
0.0874 USD -2.96% Intraday chart for Kraig Biocraft Laboratories, Inc. -11.44% +126.10%
Apr. 29 Kraig Biocraft Laboratories, Inc. Reports Signing Agreements in South East Asia CI
Apr. 22 Kraig Biocraft Laboratories, Inc. Successfully Completes Recombinant Cocoon Production from Spring Trials CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Kraig Biocraft Laboratories, Inc. Reports Signing Agreements in South East Asia
CI
Kraig Biocraft Laboratories, Inc. Successfully Completes Recombinant Cocoon Production from Spring Trials
CI
Kraig Biocraft Laboratories Signs Agreement in Vietnam's Silk Production Capital
CI
Kraig Biocraft Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Kraig Biocraft Laboratories, Inc. Provides Update on Launch of Spring Trials
CI
Kraig Biocraft Laboratories, Inc. Announces New Premium Spider Silk and Pima Cotton Composite Yarn
CI
Kraig Biocraft Laboratories, Inc. Announces New Spider Silk Production Facility in Vietnam's Silk Capital
CI
Kraig Biocraft Laboratories, Inc. Announces the Successful Creation of A New Recombinant Spider Silk Hybrid
CI
Kraig Biocraft Laboratories, Inc. Announces Early Start to Production Season with Successful Small Batch Delivery of Spider Silk
CI
Kraig Biocraft Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Kraig Biocraft Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Kraig Biocraft Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Kraig Biocraft Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Kraig Biocraft Laboratories Delivers the First Two Hybrid Dragon Silk™ Silkworm Strains for Commercial Production
CI
Kraig Biocraft Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Kraig Biocraft Laboratories Expands Operational Footprint in Vietnam
CI
Kraig Biocraft Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Kraig Biocraft Laboratories Introduces New, Enhanced Line of Dragon Silk™ Silkworms for Commercial Production
CI
Kraig Biocraft Laboratories, Inc. in Collaboration with Its Joint Venture Partner, Kings Group, the Company Has Selected A High-Quality Garment Manufacturer to Produce Spydasilk's(Tm) First Apparel Line
CI
Kraig Biocraft Laboratories Subcontractor Pilot Production Has Achieved Required Spider Silk Production Levels for the Spydasilk™ Apparel Launch
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KBLB Stock
  4. News Kraig Biocraft Laboratories, Inc.
  5. Highlights